Badgley, Phelps & Bell’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $25.3M | Buy |
203,963
+10,199
| +5% | +$1.28M | 0.94% | 32 |
|
|
2021
Q1 | $22.9M | Sell |
193,764
-3,542
| -2% | -$415K | 0.95% | 30 |
|
|
2020
Q4 | $23.1M | Buy |
197,306
+5,561
| +3% | +$612K | 1% | 30 |
|
|
2020
Q3 | $19.9M | Buy |
191,745
+5,740
| +3% | +$576K | 0.98% | 31 |
|
|
2020
Q2 | $17.1M | Buy |
186,005
+2,791
| +2% | +$268K | 0.94% | 36 |
|
|
2020
Q1 | $16.5M | Buy |
183,214
+4,145
| +2% | +$441K | 1.09% | 24 |
|
|
2019
Q4 | $20.3M | Buy |
179,069
+4,472
| +3% | +$491K | 1.07% | 24 |
|
|
2019
Q3 | $19M | Buy |
174,597
+6,559
| +4% | +$684K | 1.08% | 25 |
|
|
2019
Q2 | $16.4M | Sell |
168,038
-36
| -0% | -$3.29K | 0.95% | 37 |
|
|
2019
Q1 | $15.3M | Buy |
168,074
+9,425
| +6% | +$844K | 0.93% | 37 |
|
|
2018
Q4 | $14.4M | Buy |
158,649
+40,819
| +35% | +$3.81M | 1.04% | 29 |
|
|
2018
Q3 | $11.6M | Buy |
117,830
+3,787
| +3% | +$350K | 0.71% | 58 |
|
|
2018
Q2 | $9.76M | Sell |
114,043
-1,780
| -2% | -$149K | 0.63% | 68 |
|
|
2018
Q1 | $9.29M | Buy |
115,823
+5,424
| +5% | +$447K | 0.62% | 75 |
|
|
2017
Q4 | $8.91M | Buy |
110,399
+4,265
| +4% | +$342K | 0.61% | 75 |
|
|
2017
Q3 | $8.25M | Buy |
106,134
+1,744
| +2% | +$145K | 0.61% | 78 |
|
|
2017
Q2 | $9.27M | Buy |
104,390
+970
| +0.9% | +$81.8K | 0.72% | 62 |
|
|
2017
Q1 | $8.33M | Buy |
103,420
+24,459
| +31% | +$1.91M | 0.67% | 71 |
|
|
2016
Q4 | $5.62M | Sell |
78,961
-31,815
| -29% | -$2.5M | 0.49% | 92 |
|
|
2016
Q3 | $9.57M | Buy |
110,776
+861
| +0.8% | +$75K | 0.84% | 39 |
|
|
2016
Q2 | $9.54M | Buy |
109,915
+3,545
| +3% | +$287K | 0.87% | 38 |
|
|
2016
Q1 | $7.98M | Buy |
106,370
+2,456
| +2% | +$185K | 0.75% | 49 |
|
|
2015
Q4 | $7.99M | Sell |
103,914
-4,415
| -4% | -$332K | 0.79% | 52 |
|
|
2015
Q3 | $7.25M | Buy |
108,329
+335
| +0.3% | +$24.7K | 0.76% | 58 |
|
|
2015
Q2 | $8M | Sell |
107,994
-340
| -0.3% | -$26K | 0.78% | 57 |
|
|
2015
Q1 | $8.45M | Buy |
108,334
+100,223
| +1,236% | +$7.6M | 0.83% | 51 |
|
|
2014
Q4 | $586K | Sell |
8,111
-70
| -0.9% | -$4.86K | 0.06% | 119 |
|
|
2014
Q3 | $507K | Buy |
8,181
+4,120
| +101% | +$262K | 0.05% | 117 |
|
|
2014
Q2 | $259K | Buy |
4,061
+757
| +23% | +$46K | 0.03% | 124 |
|
|
2014
Q1 | $203K | Sell |
3,304
-239
| -7% | -$13.9K | 0.02% | 130 |
|
|
2013
Q4 | $203K | Buy |
+3,543
| New | +$201K | 0.02% | 130 |
|
Other funds holding MDT
WA
Badgley, Phelps & Bell's MDT Position: Q2 2021 in Review
Badgley, Phelps & Bell increased its Medtronic (MDT) stake by 5.3% in Q2 2021, buying an estimated $1.28M and bringing the position to 203,963 shares worth $25.3M. The position accounts for 0.94% of the portfolio, ranked #32.
Badgley, Phelps & Bell first reported a position in MDT in Q4 2013 and has held it in 31 quarters since. 2,003 funds tracked by Wall St. Rank hold MDT as of Q2 2021.
- Badgley, Phelps & Bell held 203,963 shares of Medtronic worth $25.3M as of Q2 2021.
- Badgley, Phelps & Bell bought 10,199 Medtronic shares in Q2 2021, an estimated $1.28M.
- Medtronic made up 0.94% of Badgley, Phelps & Bell's portfolio in Q2 2021, its #32 holding.
- Badgley, Phelps & Bell first reported a position in Medtronic in Q4 2013 and has held it in 31 quarters since.
- 2,003 funds tracked by Wall St. Rank held Medtronic as of Q2 2021.
Based on Badgley, Phelps & Bell's 13F filing for Q2 2021, filed 28 Jul 2021.